Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Sep;41(9):2047–2049. doi: 10.1128/aac.41.9.2047

Effect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.

M E Falagas 1, L McDermott 1, D R Snydman 1
PMCID: PMC164065  PMID: 9303414

Abstract

We studied the effect of pH (7.1, 6.3, and 5.8) on the in vitro susceptibilities of 59 isolates of Bacteroides fragilis and 60 isolates of other B. fragilis group species to trovafloxacin, ciprofloxacin, clindamycin, ampicillin-sulbactam, piperacillin-tazobactam, imipenem, and meropenem. For each agent tested the geometric mean MIC was highest at pH 5.8, intermediate at pH 6.3, and lowest at pH 7.1. The magnitude of the pH effect varied greatly among different antibiotics. These data show that an acidic pH decreases the in vitro susceptibilities of the B. fragilis group to several antibiotics.

Full Text

The Full Text of this article is available as a PDF (175.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asmar B. I., Thirumoorthi M. C., Buckley J. A., Kobos D. M., Dajani A. S. Cefotaxime diffusion into cerebrospinal fluid of children with meningitis. Antimicrob Agents Chemother. 1985 Jul;28(1):138–140. doi: 10.1128/aac.28.1.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bajaksouzian S., Visalli M. A., Jacobs M. R., Appelbaum P. C. Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods. Antimicrob Agents Chemother. 1996 Sep;40(9):1973–1976. doi: 10.1128/aac.40.9.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bauchet J., Pussard E., Garaud J. J. Determination of vancomycin in serum and tissues by column liquid chromatography using solid-phase extraction. J Chromatogr. 1987 Mar 6;414(2):472–476. doi: 10.1016/0378-4347(87)80076-2. [DOI] [PubMed] [Google Scholar]
  4. Bingen E., Lambert-Zechovsky N., Mariani-Kurkdjian P., Doit C., Aujard Y., Fournerie F., Mathieu H. Bacterial counts in cerebrospinal fluid of children with meningitis. Eur J Clin Microbiol Infect Dis. 1990 Apr;9(4):278–281. doi: 10.1007/BF01968060. [DOI] [PubMed] [Google Scholar]
  5. Borobio M. V., Pascual A., Dominguez M. C., Perea E. J. Effect of medium, pH, and inoculum size on activity of ceftizoxime and Sch-34343 against anaerobic bacteria. Antimicrob Agents Chemother. 1986 Oct;30(4):626–627. doi: 10.1128/aac.30.4.626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Borobio M. V., Perea E. J. Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria. Antimicrob Agents Chemother. 1984 Mar;25(3):342–343. doi: 10.1128/aac.25.3.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bryant R. E., Fox K., Oh G., Morthland V. H. Beta-lactam enhancement of aminoglycoside activity under conditions of reduced pH and oxygen tension that may exist in infected tissues. J Infect Dis. 1992 Apr;165(4):676–682. doi: 10.1093/infdis/165.4.676. [DOI] [PubMed] [Google Scholar]
  8. Bryant R. E., Mazza J. A. Effect of the abscess environment on the antimicrobial activity of ciprofloxacin. Am J Med. 1989 Nov 30;87(5A):23S–27S. doi: 10.1016/0002-9343(89)90014-4. [DOI] [PubMed] [Google Scholar]
  9. Cohen M. A., Huband M. D., Mailloux G. B., Yoder S. L., Roland G. E., Heifetz C. L. In vitro antibacterial activities of the fluoroquinolones PD 117596, PD 124816, and PD 127391. Diagn Microbiol Infect Dis. 1991 May-Jun;14(3):245–258. doi: 10.1016/0732-8893(91)90039-i. [DOI] [PubMed] [Google Scholar]
  10. Corkill J. E., Deveney J., Pratt J., Shears P., Smyth A., Heaf D., Hart C. A. Effect of pH and CO2 on in vitro susceptibility of Pseudomonas cepacia to beta-lactams. Pediatr Res. 1994 Mar;35(3):299–302. doi: 10.1203/00006450-199403000-00003. [DOI] [PubMed] [Google Scholar]
  11. Cuchural G. J., Hurlbut S., Malamy M. H., Tally F. P. Permeability to beta-lactams in Bacteroides fragilis. J Antimicrob Chemother. 1988 Dec;22(6):785–790. doi: 10.1093/jac/22.6.785. [DOI] [PubMed] [Google Scholar]
  12. Demotes-Mainard F. M., Vinçon G. A., Jarry C. H., Albin H. C. Micromethod for the determination of cefotaxime and desacetylcefotaxime in plasma and urine by high-performance liquid chromatography. J Chromatogr. 1984 Dec 12;336(2):438–445. doi: 10.1016/s0378-4347(00)85174-9. [DOI] [PubMed] [Google Scholar]
  13. Doit C., Denamur E., Picard B., Geslin P., Elion J., Bingen E. Mechanisms of the spread of penicillin resistance in Streptococcus pneumoniae strains causing meningitis in children in France. J Infect Dis. 1996 Sep;174(3):520–528. doi: 10.1093/infdis/174.3.520. [DOI] [PubMed] [Google Scholar]
  14. Friedland I. R., Paris M., Ehrett S., Hickey S., Olsen K., McCracken G. H., Jr Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother. 1993 Aug;37(8):1630–1636. doi: 10.1128/aac.37.8.1630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Friedland I. R., Paris M., Shelton S., McCracken G. H. Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae. J Antimicrob Chemother. 1994 Aug;34(2):231–237. doi: 10.1093/jac/34.2.231. [DOI] [PubMed] [Google Scholar]
  16. Gilchrist J. E., Campbell J. E., Donnelly C. B., Peeler J. T., Delaney J. M. Spiral plate method for bacterial determination. Appl Microbiol. 1973 Feb;25(2):244–252. doi: 10.1128/am.25.2.244-252.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gudmundsson A., Erlendsdottir H., Gottfredsson M., Gudmundsson S. Impact of pH and cationic supplementation on in vitro postantibiotic effect. Antimicrob Agents Chemother. 1991 Dec;35(12):2617–2624. doi: 10.1128/aac.35.12.2617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hughes C. E., Van Scoy R. E. Antibiotic therapy of pleural empyema. Semin Respir Infect. 1991 Jun;6(2):94–102. [PubMed] [Google Scholar]
  19. John C. C. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin Infect Dis. 1994 Feb;18(2):188–193. doi: 10.1093/clinids/18.2.188. [DOI] [PubMed] [Google Scholar]
  20. Jones R. N. Cefotaxime and desacetylcefotaxime antimicrobial interactions. The clinical relevance of enhanced activity: a review. Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):19–33. doi: 10.1016/0732-8893(95)00043-a. [DOI] [PubMed] [Google Scholar]
  21. Kiyota H., Machida T., Onodera S., Suzuki H., Goto H., Takamizawa S., Mitani H., Kawahara M., Igarashi H., Endoh K. [Influence of urine pH and cations on antimicrobial activities of penems]. Kansenshogaku Zasshi. 1993 May;67(5):435–439. doi: 10.11150/kansenshogakuzasshi1970.67.435. [DOI] [PubMed] [Google Scholar]
  22. Klugman K. P., Friedland I. R., Bradley J. S. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother. 1995 Sep;39(9):1988–1992. doi: 10.1128/aac.39.9.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. König C., Simmen H. P., Blaser J. Effect of pathological changes of pH, pO2 and pCO2 on the activity of antimicrobial agents in vitro. Eur J Clin Microbiol Infect Dis. 1993 Jul;12(7):519–526. doi: 10.1007/BF01970957. [DOI] [PubMed] [Google Scholar]
  24. Lebel M. H., McCracken G. H., Jr Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children. Pediatrics. 1989 Feb;83(2):161–167. [PubMed] [Google Scholar]
  25. McCracken G. H., Jr, Sakata Y. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin. Antimicrob Agents Chemother. 1985 Feb;27(2):141–145. doi: 10.1128/aac.27.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nord C. E., Dornbusch K., Olsson B. Studies on beta-lactamase in Bacteroides fragilis. Infection. 1980;8 (Suppl 2):S167–S170. doi: 10.1007/BF01639885. [DOI] [PubMed] [Google Scholar]
  27. París M. M., Ramilo O., McCracken G. H., Jr Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother. 1995 Oct;39(10):2171–2175. doi: 10.1128/aac.39.10.2171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Schaad U. B., McCracken G. H., Jr, Loock C. A., Thomas M. L. Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis. J Infect Dis. 1981 Feb;143(2):156–163. doi: 10.1093/infdis/143.2.156. [DOI] [PubMed] [Google Scholar]
  29. Simmen H. P., Battaglia H., Kossmann T., Blaser J. Effect of peritoneal fluid pH on outcome of aminoglycoside treatment of intraabdominal infections. World J Surg. 1993 May-Jun;17(3):393–397. doi: 10.1007/BF01658708. [DOI] [PubMed] [Google Scholar]
  30. Smith G. B., Dezeny G. C., Douglas A. W. Stability and kinetics of degradation of imipenem in aqueous solution. J Pharm Sci. 1990 Aug;79(8):732–740. doi: 10.1002/jps.2600790816. [DOI] [PubMed] [Google Scholar]
  31. Snydman D. R., Cuchural G. J., Jr, McDermott L., Gill M. Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis. Antimicrob Agents Chemother. 1992 Mar;36(3):540–544. doi: 10.1128/aac.36.3.540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Snydman D. R., McDermott L., Cuchural G. J., Jr, Hecht D. W., Iannini P. B., Harrell L. J., Jenkins S. G., O'Keefe J. P., Pierson C. L., Rihs J. D. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. Clin Infect Dis. 1996 Dec;23 (Suppl 1):S54–S65. doi: 10.1093/clinids/23.supplement_1.s54. [DOI] [PubMed] [Google Scholar]
  33. Solomkin J. S., Dellinger E. P., Christou N. V., Busuttil R. W. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. Ann Surg. 1990 Nov;212(5):581–591. doi: 10.1097/00000658-199011000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Takeuchi Y., Sunagawa M., Isobe Y., Hamazume Y., Noguchi T. Stability of a 1 beta-methylcarbapenem antibiotic, meropenem (SM-7338) in aqueous solution. Chem Pharm Bull (Tokyo) 1995 Apr;43(4):689–692. doi: 10.1248/cpb.43.689. [DOI] [PubMed] [Google Scholar]
  35. Tally F. P. Factors affecting the choice of antibiotics in mixed infections. J Antimicrob Chemother. 1988 Jul;22 (Suppl A):87–100. doi: 10.1093/jac/22.supplement_a.87. [DOI] [PubMed] [Google Scholar]
  36. Trang J. M., Jacobs R. F., Kearns G. L., Brown A. L., Wells T. G., Underwood F. L., Kluza R. B. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis. Antimicrob Agents Chemother. 1985 Dec;28(6):791–795. doi: 10.1128/aac.28.6.791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Viladrich P. F., Cabellos C., Pallares R., Tubau F., Martínez-Lacasa J., Liñares J., Gudiol F. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1996 Jan;40(1):218–220. doi: 10.1128/aac.40.1.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Winstanley T. G., Wilcox M. H., Spencer R. C. Effect of pH on antibiotics used to treat anaerobic infection. J Antimicrob Chemother. 1992 May;29(5):594–595. doi: 10.1093/jac/29.5.594. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES